Redefining the limits of implantable biodegradable fibers
TissueGen's proprietary technology makes possible tuned extended release formulations for drugs ranging from small molecules to temperature-sensitive biologics, driving a leap to a new level of convenience, compliance and improved outcomes physicians and patients deserve.
Our patent-protected technology is particularly well suited to creating a new class of drug-eluting devices designed to orchestrate the body's own healing processes to significantly improve clinical outcomes after trauma or surgery.
TissueGen's technology stands apart from the competition on several fronts:
1) Drugs are incorporated into our particles or fibers as they are being extruded, offering unmatched protection and tunability of release profiles.
2) Our extrusions take place at room temperature enabling us to formulate for extended release a wide range of temperature-sensitive drugs, including proteins, enzymes and antibodies.
3) Our extended release formats can vary from nanoparticles to fibers, coils and even woven meshes.
ADVANCED DRUG DELIVERY
Drug release profiles can be precisely tuned like never before possible.
By delivering growth factors along a precise gradient at the injury site, nerve regeneration can be orchestrated without requiring tissue to be harvested from elsewhere in the patient's body.
TissueGen's strong, pliable fibers may be woven, knitted, or braided to create biomimetic three-dimensional structures with unrivaled drug delivery capabilites.
TissueGen is advancing toward clinical development a pipeline of novel, extended release formulations of generic drugs for the treatment of eye, nerve, and joint injuries and diseases. Stay tuned for updates.